TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 56 filers reported holding TFF PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636 | -25.5% | 1,816 | 0.0% | 0.00% | – |
| Q2 2023 | $854 | -38.2% | 1,816 | -9.9% | 0.00% | – |
| Q1 2023 | $1,381 | -83.7% | 2,016 | -75.0% | 0.00% | – |
| Q4 2022 | $8,459 | +5.7% | 8,056 | +298.2% | 0.00% | – |
| Q3 2022 | $8,000 | -79.5% | 2,023 | -70.9% | 0.00% | – |
| Q2 2022 | $39,000 | +50.0% | 6,963 | +64.4% | 0.00% | – |
| Q1 2022 | $26,000 | -39.5% | 4,236 | -9.5% | 0.00% | – |
| Q4 2021 | $43,000 | -8.5% | 4,680 | -22.7% | 0.00% | – |
| Q3 2021 | $47,000 | -83.3% | 6,051 | -79.3% | 0.00% | – |
| Q2 2021 | $281,000 | +20.6% | 29,209 | +69.8% | 0.00% | – |
| Q1 2021 | $233,000 | +2018.2% | 17,206 | +2166.9% | 0.00% | – |
| Q4 2020 | $11,000 | 0.0% | 759 | +28.0% | 0.00% | – |
| Q3 2020 | $11,000 | 0.0% | 593 | -71.2% | 0.00% | – |
| Q4 2019 | $11,000 | – | 2,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,019,848 | $7,873,000 | 15.20% |
| Mesirow Financial Investment Management, Inc. | 40,005 | $309,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 80,000 | $618,000 | 0.59% |
| DRW Securities, LLC | 1,000,000 | $7,720,000 | 0.34% |
| GAGNON SECURITIES LLC | 282,229 | $2,179,000 | 0.32% |
| PRINCETON CAPITAL MANAGEMENT LLC | 128,037 | $988,000 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 145,295 | $1,122,000 | 0.11% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 22,066 | $170,000 | 0.10% |
| CARLSON CAPITAL L P | 227,701 | $1,758,000 | 0.09% |
| MYDA Advisors LLC | 40,000 | $309,000 | 0.09% |